Immunotherapeutic Effect of EGCG and DAC Treatment for Triple Negative Breast Cancer

Li, Kaiqi.

2018

Description
  • Abstract: Triple negative breast cancer (TNBC) is defined by lack of ER, PR or overexpression of Her2. Therefore TNBC is refractory to targeted treatments for the other classes of breast cancer. The Wnt/β-catenin signaling pathway has elevated activity in TNBC, and the Wnt repressor HBP1 is decreased in TNBC. Therefore, the Yee lab sought mechanistic treatments to induce expression of Wnt inhibito... read more
This object is in collection Permanent URL
ID:
rn301c498
To Cite:
DCA Citation Guide    EndNote